查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1575444

栓塞颗粒市场：按产品类型、应用、最终用户、材料、尺寸划分 - 2025-2030 年全球预测

Embolization Particle Market by Product Type (Drug-Eluting Beads, Microspheres, PVA Particles), Application (Neurology, Oncology, Peripheral Vascular Disease), End-User, Material, Size - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年栓塞颗粒市场估值为16亿美元，预计2024年将达17.9亿美元，复合年增长率为11.21%，预计到2030年将达到33.7亿美元。

栓塞颗粒是指医疗手术中使用的微小球体或其他形状的材料，以闭塞血管，从而控製或预防出血、切断肿瘤的血液供应，或治疗动静脉畸形并对其进行处理。医学领域非常需要其微创有效治疗子宫肌瘤、肝癌、消化道出血等复杂病症。最终用途范围主要包括依赖先进介入放射技术的医院和专业临床机构。微创手术需求的增加、放射治疗的进步以及更容易患血管疾病和癌症的人口老化推动了栓塞颗粒市场的成长。随着技术进步使客製化治疗方法更加有效，肿瘤学和个人化医疗的应用可能会扩大。医疗基础设施不断改善的新兴市场也为市场扩张提供了丰厚的机会。公司可以透过投资研究开发具有增强生物相容性和靶向能力的新型栓塞材料来抓住这些机会。然而，高成本、监管挑战以及与手术相关的风险等限制因素正在阻碍市场成长。此外，在介入放射学仍处于起步阶段的地区，执行此类手术的培训和技能要求也可能是一个限制。创新的关键领域包括开发生物分解性和药物释放型颗粒，以提高安全性和治疗效果。另一个成长途径是使用人工智慧来提高手术过程中的影像处理和瞄准精度。这个市场既是技术主导的，也是竞争激烈的，需要不断创新并遵守严格的监管标准。公司将专注于与医疗机构合作进行临床试验和回馈，并在开发週期的早期与监管机构合作，以简化核准流程并缩短新产品的上市时间。

主要市场统计
基准年[2023] 16亿美元
预测年份 [2024] 17.9亿美元
预测年份 [2030] 33.7亿美元
复合年增长率（%） 11.21%

市场动态：快速发展的栓塞颗粒市场的关键市场洞察

供需的动态交互作用正在改变栓塞颗粒市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 技术与成像模式的整合提高了栓塞的准确性和有效性
    • 改进医疗保健专业人员的培训计划，提高栓塞熟练程度
    • 以患者为中心的方法和客製化的治疗计划是栓塞实践的核心
  • 市场限制因素
    • 栓塞程序和颗粒的高成本
  • 市场机会
    • 对微创治疗的需求不断增长推动栓塞颗粒市场成长
    • 技术进步和创新带来栓塞颗粒的卓越性能和新应用
    • 政府和私营部门投资促进栓塞颗粒技术的研发
  • 市场挑战
    • 与栓塞相关的併发症和风险

波特的五力：驾驭栓塞颗粒市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解栓塞颗粒市场的外部影响

外部宏观环境因素在塑造栓塞颗粒市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解栓塞颗粒市场的竞争格局

对栓塞颗粒市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位基质栓塞颗粒市场供应商的表现评估

FPNV定位矩阵是评估栓塞颗粒市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了栓塞颗粒市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对栓塞颗粒市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 与诊断成像设备的技术整合提高了栓塞的准确性和有效性
      • 加强医护人员训练计画将提升他们使用栓塞技术的能力。
      • 以患者为中心的方法和客製化的治疗计划是栓塞实践的关键
    • 抑制因素
      • 栓塞和颗粒的高成本
    • 机会
      • 微创手术需求的增加推动栓塞颗粒市场的成长
      • 技术进步和创新带来栓塞颗粒的卓越性能和新应用
      • 政府和私营部门的投资推动了栓塞颗粒技术的研究和开发
    • 任务
      • 与栓塞相关的併发症和风险
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章栓塞颗粒市场：依产品类型

  • 药物释放型珠
  • 微球
  • 聚乙烯醇颗粒
  • 放射栓塞颗粒
  • 三丙烯酸明胶颗粒

第七章栓塞颗粒市场：依应用分类

  • 神经病学
  • 肿瘤学
  • 周围血管疾病
  • 泌尿系统

第 8 章 栓塞颗粒市场：依最终使用者分类

  • 门诊手术中心
  • 医院
  • 研究/学术机构
  • 专科诊所

第九章栓塞颗粒市场：依材料分类

  • 丙烯酸聚合物
  • 明胶
  • 聚乙烯醇（PVA）

第 10 章 栓塞颗粒市场：依规模

  • 100-300微米
  • 300-500微米
  • 500-700微米
  • 700-900微米
  • 900微米以上
  • 小于100微米

第十一章：美洲的栓塞颗粒市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第12章：亚太地区栓塞颗粒市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲的栓塞颗粒市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-2B5802CFE14F

The Embolization Particle Market was valued at USD 1.60 billion in 2023, expected to reach USD 1.79 billion in 2024, and is projected to grow at a CAGR of 11.21%, to USD 3.37 billion by 2030.

Embolization particles refer to tiny spheres or other shaped materials used in medical procedures to block blood vessels, thereby controlling or preventing bleeding, cutting off blood supply to tumors, or addressing arteriovenous malformations. Their necessity in the medical field is significant due to their minimally invasive nature and efficacy in treating complex conditions like uterine fibroids, liver cancer, and gastrointestinal bleeding. The end-use scope primarily includes hospitals and specialized clinical settings, which rely on advanced interventional radiology techniques. Market growth for embolization particles is driven by increasing demand for minimally invasive surgery, advances in radiological procedures, and an aging population prone to vascular diseases and cancer. Potential opportunities lie in expanding applications in oncology and personalized medicine as technological advancements make tailored treatment approaches more effective. Emerging markets with improving healthcare infrastructure also offer lucrative opportunities for market expansion. Companies can capture these opportunities by investing in research to develop novel embolic materials with enhanced biocompatibility and targeting capabilities. However, limitations such as high costs, regulatory challenges, and risks associated with procedures present obstacles to market growth. Training and skill requirements for conducting such procedures can also be a restraint in regions where interventional radiology is still developing. Key areas of innovation include developing biodegradable and drug-eluting particles, which can enhance safety and therapeutic outcomes. Leveraging artificial intelligence for improved imaging and targeting precision during procedures represents another avenue for growth. The nature of this market is both technology-driven and highly competitive, demanding continuous innovation and adherence to strict regulatory standards. Businesses should focus on partnerships with healthcare institutions for clinical trials and feedback, as well as engaging with regulatory bodies early in the development cycle to streamline approval processes and reduce time-to-market for new products.

KEY MARKET STATISTICS
Base Year [2023] USD 1.60 billion
Estimated Year [2024] USD 1.79 billion
Forecast Year [2030] USD 3.37 billion
CAGR (%) 11.21%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Embolization Particle Market

The Embolization Particle Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Technological integration with imaging modalities improves precision and efficacy of embolization procedures
    • Enhanced training programs for healthcare professionals increase proficiency in using embolization technologies
    • Patient-centric approaches and customized treatment plans gain prominence in embolization practices
  • Market Restraints
    • High cost of embolization procedures and particles
  • Market Opportunities
    • Increasing demand for minimally invasive procedures to drive growth in embolization particle market
    • Technological advancements and innovation leading to superior performance and new applications of embolization particles
    • Government and private sector investments boosting research and development in embolization particle technologies
  • Market Challenges
    • Complications and risks associated with embolization

Porter's Five Forces: A Strategic Tool for Navigating the Embolization Particle Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Embolization Particle Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Embolization Particle Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Embolization Particle Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Embolization Particle Market

A detailed market share analysis in the Embolization Particle Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Embolization Particle Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Embolization Particle Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Embolization Particle Market

A strategic analysis of the Embolization Particle Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Embolization Particle Market, highlighting leading vendors and their innovative profiles. These include ABK Biomedical, Bellostent, Biocompatibles International plc, Boston Scientific Corporation, BTG plc, Cook Medical, EndoShape, Guerbet Group, Hanger Inc., Imbiotechnologies, Johnson & Johnson, Kaneka Corporation, Medtronic plc, Merit Medical Systems, Penumbra Inc., Sequent Medical, Sirtex Medical, Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Embolization Particle Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Drug-Eluting Beads, Microspheres, PVA Particles, Radioembolization Particles, and Tris-Acryl Gelatin Particles.
  • Based on Application, market is studied across Neurology, Oncology, Peripheral Vascular Disease, and Urology.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, Research and Academic Institutes, and Specialty Clinics.
  • Based on Material, market is studied across Acrylic Polymers, Gelatin, and Polyvinyl Alcohol (PVA).
  • Based on Size, market is studied across 100-300 Microns, 300-500 Microns, 500-700 Microns, 700-900 Microns, 900 Microns and Above, and Less Than 100 Microns.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Technological integration with imaging modalities improves precision and efficacy of embolization procedures
      • 5.1.1.2. Enhanced training programs for healthcare professionals increase proficiency in using embolization technologies
      • 5.1.1.3. Patient-centric approaches and customized treatment plans gain prominence in embolization practices
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of embolization procedures and particles
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing demand for minimally invasive procedures to drive growth in embolization particle market
      • 5.1.3.2. Technological advancements and innovation leading to superior performance and new applications of embolization particles
      • 5.1.3.3. Government and private sector investments boosting research and development in embolization particle technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Complications and risks associated with embolization
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Embolization Particle Market, by Product Type

  • 6.1. Introduction
  • 6.2. Drug-Eluting Beads
  • 6.3. Microspheres
  • 6.4. PVA Particles
  • 6.5. Radioembolization Particles
  • 6.6. Tris-Acryl Gelatin Particles

7. Embolization Particle Market, by Application

  • 7.1. Introduction
  • 7.2. Neurology
  • 7.3. Oncology
  • 7.4. Peripheral Vascular Disease
  • 7.5. Urology

8. Embolization Particle Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals
  • 8.4. Research and Academic Institutes
  • 8.5. Specialty Clinics

9. Embolization Particle Market, by Material

  • 9.1. Introduction
  • 9.2. Acrylic Polymers
  • 9.3. Gelatin
  • 9.4. Polyvinyl Alcohol (PVA)

10. Embolization Particle Market, by Size

  • 10.1. Introduction
  • 10.2. 100-300 Microns
  • 10.3. 300-500 Microns
  • 10.4. 500-700 Microns
  • 10.5. 700-900 Microns
  • 10.6. 900 Microns and Above
  • 10.7. Less Than 100 Microns

11. Americas Embolization Particle Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Embolization Particle Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Embolization Particle Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ABK Biomedical
  • 2. Bellostent
  • 3. Biocompatibles International plc
  • 4. Boston Scientific Corporation
  • 5. BTG plc
  • 6. Cook Medical
  • 7. EndoShape
  • 8. Guerbet Group
  • 9. Hanger Inc.
  • 10. Imbiotechnologies
  • 11. Johnson & Johnson
  • 12. Kaneka Corporation
  • 13. Medtronic plc
  • 14. Merit Medical Systems
  • 15. Penumbra Inc.
  • 16. Sequent Medical
  • 17. Sirtex Medical
  • 18. Stryker Corporation
  • 19. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. EMBOLIZATION PARTICLE MARKET RESEARCH PROCESS
  • FIGURE 2. EMBOLIZATION PARTICLE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EMBOLIZATION PARTICLE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. EMBOLIZATION PARTICLE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EMBOLIZATION PARTICLE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EMBOLIZATION PARTICLE MARKET DYNAMICS
  • TABLE 7. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY DRUG-ELUTING BEADS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PVA PARTICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY RADIOEMBOLIZATION PARTICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY TRIS-ACRYL GELATIN PARTICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY UROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY ACRYLIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY GELATIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY POLYVINYL ALCOHOL (PVA), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY 100-300 MICRONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY 300-500 MICRONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY 500-700 MICRONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY 700-900 MICRONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY 900 MICRONS AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL EMBOLIZATION PARTICLE MARKET SIZE, BY LESS THAN 100 MICRONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES EMBOLIZATION PARTICLE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 101. MALAYSIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 106. PHILIPPINES EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 111. SINGAPORE EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 116. SOUTH KOREA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 121. TAIWAN EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 126. THAILAND EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 131. VIETNAM EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 142. DENMARK EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 147. EGYPT EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 152. FINLAND EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 157. FRANCE EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 162. GERMANY EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 167. ISRAEL EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 172. ITALY EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 177. NETHERLANDS EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 182. NIGERIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 187. NORWAY EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 192. POLAND EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 197. QATAR EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 202. RUSSIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 207. SAUDI ARABIA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 212. SOUTH AFRICA EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 217. SPAIN EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 222. SWEDEN EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 227. SWITZERLAND EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 232. TURKEY EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED ARAB EMIRATES EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 242. UNITED KINGDOM EMBOLIZATION PARTICLE MARKET SIZE, BY SIZE, 2018-2030 (USD MILLION)
  • TABLE 243. EMBOLIZATION PARTICLE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 244. EMBOLIZATION PARTICLE MARKET, FPNV POSITIONING MATRIX, 2023